$3.73
▲ +7.3% Today
as of Sep 4, 16:52 ET
Last 30 days
Recent Press Releases & News
Nasus Pharma Files $50 Million Shelf Registration
NSRX: First Half 2026 Financial Results
Nasus Pharma Announces Transition of Chief Financial Officer
Overview
52-week range
$1.98
$9.50
23% of range
Avg surprise (last 0)
—
Avg reaction (last 0)
—
Earnings trends
Implied volatility — last 90 days
No IV snapshots yet for NSRX.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.